BFM
LLY icon

Boothbay Fund Management’s Eli Lilly LLY Stock Holding History

Boothbay Fund Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,400
Closed -$5.79M – 1794
2024
Q2 		$5.79M Buy
+6,400
New +$5.12M 0.14% 187
2023
Q2 		– Sell
-21,400
Closed -$7.35M – 2073
2023
Q1 		$7.35M Buy
21,400
+7,200
+51% +$2.43M 0.15% 139
2022
Q4 		$5.19M Sell
14,200
-57,600
-80% -$20.4M 0.12% 223
2022
Q3 		$23.2M Buy
71,800
+70,700
+6,427% +$22.4M 0.58% 7
2022
Q2 		$357K Sell
1,100
-1,700
-61% -$510K 0.01% 1358
2022
Q1 		$802K Buy
+2,800
New +$721K 0.02% 1033
2021
Q4 		– Sell
-9,900
Closed -$2.29M – 2067
2021
Q3 		$2.29M Buy
+9,900
New +$2.44M 0.06% 398
2021
Q1 		– Sell
-104
Closed -$1.76M – 1673
2020
Q4 		$1.76M Buy
+104
New +$15.5K 0.07% 304

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boothbay Fund Management's LLY Position: Q2 2026 in Review

Boothbay Fund Management increased its Eli Lilly (LLY) stake by 2.2% in Q2 2026, buying an estimated $56.2K and bringing the position to 2,584 shares worth $3.1M. The position accounts for 0.04% of the portfolio, ranked #518.

Boothbay Fund Management first reported a position in LLY in Q3 2015 and has held it in 22 quarters since. The position peaked at $14.5M in Q1 2023. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Boothbay Fund Management held 2,584 shares of Eli Lilly worth $3.1M as of Q2 2026.
  • Boothbay Fund Management bought 55 Eli Lilly shares in Q2 2026, an estimated $56.2K.
  • Eli Lilly made up 0.04% of Boothbay Fund Management's portfolio in Q2 2026, its #518 holding.
  • Boothbay Fund Management first reported a position in Eli Lilly in Q3 2015 and has held it in 22 quarters since.
  • Boothbay Fund Management's Eli Lilly position peaked at $14.5M in Q1 2023.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.